SeaStar Medical Holding Corp ICU.OQ ICU.O is expected to show a rise in quarterly revenue when it reports results on August 13 for the period ending June 30 2025
The Denver Colorado-based company is expected to report revenue of $200 thousand, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for SeaStar Medical Holding Corp is for a loss of 43 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for SeaStar Medical Holding Corp is $7.00, about 88.9% above its last closing price of $0.78
This summary was machine generated August 11 at 20:32 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)